期刊
EUROPEAN JOURNAL OF PHARMACOLOGY
卷 740, 期 -, 页码 312-320出版社
ELSEVIER SCIENCE BV
DOI: 10.1016/j.ejphar.2014.06.051
关键词
Curcumin; AD; A beta; Autophagy; PI3K/Akt/mTOR pathways
资金
- National Natural Science Foundation of China [NSFC: 81271426, 81100948]
Autophagy is a lysosomal degradation pathway, which is essential for cell survival, proliferation, differentiation and homeostasis. It is well known that beta-amyloid (A beta) aggregation is one of key characteristics for Alzheimer's disease (AD), which triggers a complex pathological cascade, leading to neurodegeneration. Recent studies have shown that AP peptide is generated from amyloid p precursor protein (APP) during autophagic turnover of APP-rich organelles by autophagy. A beta generation during normal autophagy is subsequently degraded by lysosomes. Curcumin, a nature plant extraction, has been reported to inhibit the generation and deposition of A beta; however, the underlying mechanisms are not fully understood yet. In the present study, we reported that curcumin treatment not only attenuated cognitive impairment detected by Morris water maze test, but also inhibited the generation of A beta investigated by immunohistochemistry in APP/PSI double transgenic AD mice. Moreover, curcumin induced autophagy in the mice, evidenced by LC3 immunofluorescence analysis and western blot assays on LC3. Furthermore, we found that curcumin significantly decreased the expression of Phosphaticlylinositol 3-Kinase (PI3K), phosphorylated Akt and rapamycin (mTOR) at protein levels, respectively. Taken together, our data suggests that curcumin inhibits A beta generation and induces of autophagy by downregulating PI3K/Akt/mTOR signaling pathway, and further shows a neuroprotective effect. Meanwhile curcumin might be a candidate neuroprotective agent for AD patients treatment by inducing autophagy. (C) 2014 Elsevier B.V. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据